Xilio Therapeutics
XLO
$1.14
Share price
5.56%
Change (1 day)
-63.58%
Change (1 year)
Categories
Xilio Therapeutics (XLO) - P/B ratio
P/B ratio as of May 2024 : 0.7594
According to Xilio Therapeutics's latest financial reports the company has a price-to-book ratio of 0.7594.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Xilio Therapeutics - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.2884 | -58.77% |
| 2022-12-31 | 0.6995 | -70.49% |
| 2021-12-31 | 2.37 | |
| 2020-12-31 | N/A |